Akebia Therapeutics, Inc.
AKBA
$0.88
$0.033.87%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.28% | 43.46% | 256.36% | 389.27% | 247.62% |
| Total Receivables | -26.51% | 1.62% | 36.85% | 105.85% | 144.61% |
| Inventory | -22.09% | -34.14% | -3.90% | -9.03% | -30.01% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -4.48% | -32.99% | -25.28% | 13.12% | 6.86% |
| Total Current Assets | -2.18% | 19.48% | 122.22% | 158.03% | 109.33% |
|
|
|||||
| Total Current Assets | -2.18% | 19.48% | 122.22% | 158.03% | 109.33% |
| Net Property, Plant & Equipment | -5.03% | -62.06% | -53.11% | -46.67% | -41.90% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 21.62% | 47.55% | 59.67% | 49.12% | 148.57% |
| Total Assets | 1.18% | 16.87% | 70.65% | 75.80% | 56.95% |
|
|
|||||
| Total Accounts Payable | -18.45% | -33.75% | 39.56% | -25.25% | 14.32% |
| Total Accrued Expenses | 51.58% | 135.14% | 176.91% | 170.44% | 117.17% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 113.14% | 191.21% | 132.35% | 166.76% | 147.46% |
| Total Finance Division Other Current Liabilities | -21.04% | 28.76% | 18.93% | 63.66% | -51.85% |
| Total Other Current Liabilities | -21.04% | 28.76% | 18.93% | 63.66% | -51.85% |
| Total Current Liabilities | 35.50% | 90.61% | 101.37% | 102.98% | 10.64% |
|
|
|||||
| Total Current Liabilities | 35.50% | 90.61% | 101.37% | 102.98% | 10.64% |
| Long-Term Debt | -11.60% | -12.15% | 0.42% | 97.21% | 94.69% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 555.74% | -- | -- | -- | -89.35% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -87.11% | -74.01% | -51.61% | -89.35% | -60.27% |
| Total Liabilities | 2.61% | 17.35% | 27.46% | 25.24% | 24.58% |
|
|
|||||
| Common Stock & APIC | 1.50% | 1.37% | 5.35% | 6.72% | 6.21% |
| Retained Earnings | -1.77% | -1.23% | -0.32% | -0.96% | -2.23% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -14.39% | 11.37% | 166.30% | 182.52% | 186.58% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -14.39% | 11.37% | 166.30% | 182.52% | 186.58% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.39% | 11.37% | 166.30% | 182.52% | 186.58% |
|
|
|||||